Informed Prostate Cancer Patient Support

  IPCSG Newsletter: Examining the Evidence Bottom Line: Recent case reports suggest potential anti-cancer effects of chlorine dioxide solution (CDS) in metastatic prostate cancer patients, but these findings are based on uncontrolled case studies without peer review. Major health authorities continue to warn against its use due to serious safety concerns. What Is Chlorine Dioxide Solution (CDS)? Chlorine dioxide solution (CDS) is a concentrated 0.3% (3000ppm) aqueous solution of chlorine dioxide, with no sodium chlorite (NaClO2) content in solution and has a neutral pH. CDS is different from Miracle Mineral Solution (MMS), which contains sodium chlorite and acid that continuously produces chlorine dioxide in an acidic solution (pH 3-5). Recent Research Findings Case Reports in Prostate Cancer A 2024 case report published in Salud, Ciencia y Tecnología documented a 64-year-old Mexican male with metastatic prostate cancer who opted for CDS treatment after declining convention...

Breakthrough Stem Cell Therapy Could Revolutionize Cancer Treatment: What It Means for Prostate Cancer Patients First-in-Human Clinical Trial Demonstrates "Internal Immune Factory" Approach In a groundbreaking development that could transform the landscape of cancer immunotherapy, UCLA researchers have successfully demonstrated the world's first clinical trial using genetically engineered stem cells to create a renewable supply of cancer-fighting T cells within patients' bodies. This revolutionary approach, published in Nature Communications in August 2025, represents a significant advancement toward more durable cancer treatment options. The Science Behind the Breakthrough The Problem with Current Immunotherapy Current cancer immunotherapies, including CAR-T cell treatments that have shown remarkable success in blood cancers, face a critical limitation: the engineered T cells eventually die off or become exhausted, often allowing cancer to return. This...

NAVIGATING MEDICARE'S 2026 CHANGES: A SURVIVAL GUIDE FOR PROSTATE CANCER PATIENTS Special Report for the Informed Prostate Cancer Support Group Newsletter Medicare is undergoing its most significant transformation in decades, with 2026 bringing both unprecedented challenges and unexpected opportunities for San Diego men with prostate cancer. While premiums are rising substantially, new reforms provide stronger protection against catastrophic drug costs than ever before. THE CRITICAL SITUATION Medicare Part D premiums are increasing dramatically as the federal government scales back premium subsidies. The Premium Stabilization Demonstration is reducing support from $15 to $10 monthly while allowing premium increases up to $50 (previously capped at $35). Combined with an 11.6% increase in Part B premiums to $206.50 monthly, most Medicare beneficiaries face significantly higher healthcare costs. Simultaneously, major insurers are canceling Medicare Advantage plans nat...

Betty.care (also known as "Better Surgery") is a free digital perioperative platform developed by the French company AIMED2 . It's designed to transform the surgical experience by providing comprehensive support from pre-surgery preparation through complete recovery. Revolutionary Study Shows 83% Continence Recovery at 6 Weeks with Digital Support Program September 19, 2025 - IPCSG Newsletter Bottom Line: A groundbreaking multicenter study published today demonstrates that men using a digital coaching program before and after radical prostatectomy achieved 83.3% continence recovery at just 6 weeks post-surgery, compared to 68.4% in the standard care group—a remarkable 15-percentage-point improvement that could transform prostate cancer surgery outcomes. The Study at a Glance Researchers from multiple European medical centers have published the largest study to date on digital perioperative programs for radical prostatectomy in Prostate Cancer and Prostati...